CEFAZOLIN INJECTION

The Defense Logistics Agency awarded a delivery order under the IDIQ contract SPE2DX-25-D-8022 to Cardinal Health, Inc. (CAGE 00E55) for the purchase of one package of cefazolin injection, identified by NSN 6505-01-480-2501, at a total price of $35.82. The order was issued on August 2, 2026, with performance required by August 3, 2026, for delivery to the USS ZUMWALT (DDG 1000) at FPO AP 96693. All delivery terms are FOB Destination, and the contractor is responsible for payment of freight, although inspection and acceptance occur at the destination by a government representative. The contract is structured as a commercial item acquisition under FAR 52.212 series clauses, with no options or quantity variances permitted. Cardinal Health, Inc. is certified as a small business and small disadvantaged women-owned business, triggering applicable small business reporting obligations under FAR 52.212-3 and 52.212-5, though no subcontracting plan is indicated. Payment is processed via the Defense Finance and Accounting Service in Columbus, Ohio, under funding identifier 97X4930 5CBX 001 2620 S33189 and appropriation code SL4701, with fast pay net 15 terms applied. Items must be shipped using traceable methods only, with parcel post prohibited, and all packaging must include identification numbers from the contract or order form to support military logistics tracking; specific barcoding or labeling standards such as MIL-STD-129 are implied by reference to DLA Fleet MILSTRIP procedures but not formally detailed. The contract is administered by Lisa Quinn as the contracting officer, with Catherine Gilbert and Michelle Pampel acting as administrative contacts. No formal evaluation factors, special requirements like security clearances or key personnel clauses, or modification numbers are documented, and while electronic submission via EDI is referenced, explicit file format requirements are not provided. The $35.82 value reflects a single-line-item delivery under a larger $20 million IDIQ contract vehicle, with no indication of additional line items or future obligations under this specific order.